Remdesivir for the Treatment of Covid-19 — Preliminary Report

RCT (n=1,063) found remdesivir was superior to placebo in shortening the time to recovery in adults hospitalised with Covid-19 (median recovery time 11 days [95% CI 9 to 12], vs 15 days [95% CI, 13 to 19] in those who received placebo).

New England Journal of Medicine